在治疗腿部肌肉缩后的肉毒毒素治疗肺栓塞
Xiaoli Wang1, Xiaofei Li2, Mosheng Yu1
1From the Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Plastic and reconstructive surgery. Global open
|February 7, 2024
概括
在东亚妇女中,用于小腿肌肉缩的肉毒素A注射会导致深静脉血栓和肺栓塞. 这一案例凸显了需要仔细选择和监测患者,以防止严重的并发症.
科学领域:
- 整形外科 整形外科 整形外科
- 血管外科 血管外科
- 皮肤病学 皮肤病学
背景情况:
- 牛腿肌肉缩是东亚妇女的常见问题,注射肉毒素是一种流行的微创治疗方法.
- 毒素A经常用于化品减小小腿,因为它的有效性和相比手术选择的低创伤.
研究的目的:
- 调查肉毒素A注射用于小腿肌肉缩和DVT和PE的发展之间的潜在联系.
- 分析一个年轻女性的具体案例,在此类治疗后患有DVT和PE.
- 为这种不良事件提出管理和预防策略.
主要方法:
- 一个22岁的女性患有双边小腿肌肉缩的病例报告.
- 审查患者的症状,诊断成像 (超声波,CT血管造影) 和治疗过程.
- 分析潜在的病因因素,将肉毒素治疗与血栓栓塞事件联系起来.
主要成果:
- 患者在注射后三天出现左下肢DVT和随后的多重PE.
- 超声波证实了深层和表面静脉血.
- 电脑图谱血管学揭示了肺动脉栓塞.
结论:
- 毒素治疗小腿肌肉缩可能与DVT和PE的风险增加有关.
- 需要保持警和进一步研究,以了解和减轻这种风险.
- 实施预防措施和仔细监测患者至关重要.
更多相关视频
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
682
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
682
Skeletal Muscle Relaxants: Adverse Effects
373
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
373
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
422
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
422
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Depolarizing Blockers: Pharmocokinetics
327
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
327


